Could an existing antiviral ease long COVID? small study tests remdesivir

NCT ID NCT05911906

Completed Symptom relief Sponsor: University of Derby Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether the antiviral drug remdesivir could help people with Long COVID. 73 adults with confirmed Long COVID received five daily doses of the drug through an IV. Researchers measured how many people completed the treatment and tests, and how well they tolerated it. The goal was to see if a larger trial is possible, not to prove the drug works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Remdesivir (an antiviral drug given intravenously)
What this could lead to: If this works, it could point toward a treatment that reduces Long COVID symptoms and improves quality of life.
What could go wrong: This is a small feasibility study, not a large trial. It focuses on whether the drug can be given practically, not on proving it works. Many people with Long COVID may not benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19 long COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 SARS-COV-2 INFECTION

Contacts and locations

Locations

Derbyshire Community Health Services NHS Foundation Trust

Chesterfield, S42 7JE, United Kingdom
Royal Derby Hospital (UHDB)

Derby, D22 3NE, United Kingdom
University of Derby

Derby, Derby, DE22 1GB, United Kingdom
University of Exeter / Royal Devon University Healthcare NHS FT

Exeter, EX4 4PY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.